UPDATE 1-Ariad Pharma's lung cancer drug gets breakthrough therapy status
October 02, 2014 at 10:05 AM EDT
Oct 2 (Reuters) - Ariad Pharmaceuticals Inc said its experimental lung cancer drug was granted "breakthrough therapy" status by the U.S. Food and Drug Administration, sending the company's shares up as much as 13 percent.
